← Back to Search

Behavioral Intervention

Supportive care (group therapy sessions) for Blood Cancers

N/A
Recruiting
Led By Chun Tao, Ph.D., L.P.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Being an adult (18 years or older)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 1 month post session 6
Awards & highlights

Study Summary

"This trial is testing if acceptance and commitment therapy and compassion-based virtual group therapy can help improve the mental well-being of cancer patients. Cancer diagnosis and treatment can lead to distress and decreased quality of life,

Who is the study for?
This trial is for cancer patients seeking to improve their psychological wellbeing. It's open to those experiencing distress or a decreased quality of life due to their diagnosis, treatment, or symptoms. Specific eligibility details are not provided but typically include health status and consent.Check my eligibility
What is being tested?
The study examines the effectiveness of virtual group therapies: Acceptance and Commitment Therapy (ACT) and Compassion-Based Therapy, in enhancing understanding, compassion, flexibility, and overall mental wellness in cancer patients.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects are not expected. Participants may experience emotional discomfort discussing sensitive topics during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 1 month post session 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 1 month post session 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Participant perceived compassion and understanding by the group therapy provider - SCQ
Patients' self-reported psychological flexibility - COMPACT-15
Patients' self-reported psychological flexibility - Psy-Flex
+1 more
Secondary outcome measures
Meaning and purpose
Posttraumatic growth
Self reported mindfulness
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (group therapy sessions)Experimental Treatment2 Interventions
Patients attend acceptance and commitment virtual group therapy sessions over 1.5 hours each, once a week for 6 weeks.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,216 Previous Clinical Trials
3,767,288 Total Patients Enrolled
Chun Tao, Ph.D., L.P.Principal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this medical study currently accepting new participants?

"According to clinicaltrials.gov, this investigation is currently seeking potential participants. The initial posting date of the trial was December 26th, 2023, with the latest update noted on January 30th, 2024."

Answered by AI

What are the projected results that researchers hope to achieve with this investigation?

"The primary focus of this investigation is to gauge the perceived compassion and understanding from the group therapy provider as measured by SCQ, spanning from baseline to 1 month post session 6. Secondary objectives encompass examining Meaning and purpose utilizing a 5-item Presence of Meaning subscale derived from the MLQ, evaluating Self-compassion with a 12-item SCS-SF scale rating responses on a range from almost never (1) to almost always (5), and scrutinizing Posttraumatic growth through a 10-item PTGI-SF survey graded between 0 denoting no change following cancer diagnosis up to 5 depicting significant impact experienced"

Answered by AI

What is the current number of participants involved in this research investigation?

"Affirmative. Records on clinicaltrials.gov display that this trial is currently open for enrollment. Initially shared on December 26, 2023, and last revised on January 30, 2024, the study aims to recruit a total of 200 participants from one designated site."

Answered by AI
~133 spots leftby Dec 2026